Does RIOCIGUAT Cause Pulmonary arterial hypertension? 436 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 436 reports of Pulmonary arterial hypertension have been filed in association with RIOCIGUAT (Adempas). This represents 2.4% of all adverse event reports for RIOCIGUAT.
436
Reports of Pulmonary arterial hypertension with RIOCIGUAT
2.4%
of all RIOCIGUAT reports
175
Deaths
319
Hospitalizations
How Dangerous Is Pulmonary arterial hypertension From RIOCIGUAT?
Of the 436 reports, 175 (40.1%) resulted in death, 319 (73.2%) required hospitalization, and 17 (3.9%) were considered life-threatening.
Is Pulmonary arterial hypertension Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIOCIGUAT. However, 436 reports have been filed with the FAERS database.
What Other Side Effects Does RIOCIGUAT Cause?
Death (4,500)
Dyspnoea (2,881)
Headache (2,462)
Dizziness (2,208)
Hypotension (2,192)
Nausea (2,020)
Hospitalisation (1,864)
Diarrhoea (1,790)
Fatigue (1,638)
Vomiting (1,124)
What Other Drugs Cause Pulmonary arterial hypertension?
TREPROSTINIL (3,240)
MACITENTAN (2,390)
AMBRISENTAN (1,965)
SELEXIPAG (1,387)
EPOPROSTENOL (1,055)
BOSENTAN (778)
TADALAFIL (680)
SILDENAFIL (487)
ILOPROST (284)
BOSENTAN\BOSENTAN (245)
Which RIOCIGUAT Alternatives Have Lower Pulmonary arterial hypertension Risk?
RIOCIGUAT vs RIPRETINIB
RIOCIGUAT vs RISANKIZUMAB
RIOCIGUAT vs RISANKIZUMAB-RZAA
RIOCIGUAT vs RISDIPLAM
RIOCIGUAT vs RISEDRONATE